Molecular Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention Chemical and Biological Aspects of Inflammation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by James, R. M.
Right arrow Articles by Patek, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by James, R. M.
Right arrow Articles by Patek, C. E.
Molecular Cancer Research 1:820-825 (2003)
© 2003 American Association for Cancer Research


Cancer Genes and Genomics

K-ras Proto-Oncogene Exhibits Tumor Suppressor Activity As Its Absence Promotes Tumorigenesis in Murine Teratomas1

Roberta M. James1, Mark J. Arends2, Sarah J. Plowman1, David G. Brooks2, Colin G. Miles3, John D. West4 and Charles E. Patek1

1 Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Edinburgh, United Kingdom;
2 University of Cambridge Pathology Department, Addenbrooke's Hospital, Cambridge, United Kingdom;
3 Comparative and Developmental Genetics Section, MRC Human Genetics Unit, Western General Hospital, Edinburgh, United Kingdom; and
4 Division of Reproductive and Developmental Sciences, Genes and Development Group, University of Edinburgh, Hugh Robson Building, Edinburgh, United Kingdom

Requests for reprints: Roberta M. James, Sir Alastair Currie Cancer Research UK Laboratories, Molecular Medicine Centre, The University of Edinburgh, Western General Hospital, Crewe Road, Edinburgh, EH4 2XU, United Kingdom. Phone: 44-131-651-1080; Fax: 44-131-651-1072. E-mail: roberta.james{at}ed.ac.uk

Ras proteins transduce signals from membrane-bound receptors via multiple downstream effector pathways and thereby affect fundamental cellular processes, including proliferation, apoptosis, and differentiation. K-ras activating mutations play a key role in neoplastic progression and are particularly prevalent in colorectal, pancreatic, and lung cancers. The present study addressed whether the K-ras proto-oncogene displays a tumor suppressor function by comparative analysis of mouse teratomas derived from wild-type embryonic stem (ES) cells, K-ras null (K-ras-/-) ES cells, and K-ras-/- ES cells that stably reexpress either wild-type K-rasgly12 or oncogenic K-rasval12. K-ras-/- and K-rasval12 teratomas were significantly larger than teratomas that expressed wild-type K-ras, contained significantly higher proportions of undifferentiated embryonal carcinoma-like cells, and showed significantly increased mitotic activity. However, K-rasval12 but not K-ras-/- teratomas exhibited significantly higher levels of apoptosis than wild-type teratomas. K-ras-/- and K-rasval12 ES cells showed a higher capacity for stem cell self-renewal in vitro compared with wild-type ES cells, and reexpression of K-rasgly12 in K-ras-/- ES cells restored the K-ras-/- phenotype to wild-type values. Thus, in view of evidence that tumors can derive from tissue stem cells and that tumors harbor "cancer stem cells," aberrant K-ras expression could promote neoplastic progression by increasing their capacity for self-renewal.

Key Words: K-ras • tumor suppressor • stem cell • self-renewal • teratoma




This article has been cited by other articles:


Home page
BloodHome page
F. Dayyani, J. Wang, J.-R. J. Yeh, E.-Y. Ahn, E. Tobey, D.-E. Zhang, I. D. Bernstein, R. T. Peterson, and D. A. Sweetser
Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival
Blood, April 15, 2008; 111(8): 4338 - 4347.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Binetruy, L. Heasley, F. Bost, L. Caron, and M. Aouadi
Concise Review: Regulation of Embryonic Stem Cell Lineage Commitment by Mitogen-Activated Protein Kinases
Stem Cells, May 1, 2007; 25(5): 1090 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Z. Hao, X. Li, T. Qiao, J. Zhang, X. Shao, and D. Fan
Distribution of CIAPIN1 in Normal Fetal and Adult Human Tissues
J. Histochem. Cytochem., April 1, 2006; 54(4): 417 - 426.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z.-R. Yuan, R. Wang, J. Solomon, X. Luo, H. Sun, L. Zhang, and Y. Shi
Identification and Characterization of Survival-Related Gene, a Novel Cell Survival Gene Controlling Apoptosis and Tumorigenesis
Cancer Res., December 1, 2005; 65(23): 10716 - 10724.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
R. Diaz, L. Lopez-Barcons, D. Ahn, A. Garcia-Espana, A. Yoon, J. Matthews, R. Mangues, R. Perez-Soler, and A. Pellicer
Complex effects of Ras proto-oncogenes in tumorigenesis
Carcinogenesis, April 1, 2004; 25(4): 535 - 539.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.